Operating Lease, Right-of-Use Asset in USD of Silexion Therapeutics Corp from Q4 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Silexion Therapeutics Corp quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2023 to Q3 2025.
  • Silexion Therapeutics Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $442K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Silexion Therapeutics Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $442K +$442K 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $472K +$332K +237% 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $502K 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $530K +$332K +168% 31 Dec 2024 10-Q 12 Nov 2025
Q3 2024 $0 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $140K 30 Jun 2024 10-Q 29 Aug 2024
Q4 2023 $198K 31 Dec 2023 8-K 20 Aug 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.